HCEI and PIE: Is it time for pharma to be proactive in the argument over cost-effectiveness?Thought Leadership
The FDA and the US Department of Health and Human Services published final guidance on the presentation of health care economic information (HCEI) and preapproval information exchange (PIE). This is a new opportunity for manufacturers to engage with payers around cost-effectiveness. Precision’s Jeremy Schafer views it from the manufacturer’s perspective in his article for KNect365.
To read the full article, please click here.